• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去甲基化剂5-氮杂-2'-脱氧胞苷可上调MAGE-1肿瘤抗原的表达。

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

作者信息

Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J, Rosenberg S A

机构信息

Surgery Branche, National Cancer Institute, Bethesda, Maryland.

出版信息

Cancer Res. 1994 Apr 1;54(7):1766-71.

PMID:7511051
Abstract

MAGE-1 is a gene that encodes an antigen on a melanoma cell line that is recognized by cytolytic T-cells. We have used a reverse transcription-polymerase chain reaction assay to analyze expression of the MAGE-1 gene by cell lines from different types of tumors, melanomas from different stages of disease progression, normal diploid cell lines, and melanocyte and nevus tissue from which malignant melanomas are derived. MAGE-1 is expressed by melanoma tissue from all stages of disease, but not melanocytes, nevus tissue, or any normal diploid cell line tested. A fraction of tumor lines derived from various epithelial and neuroectodermal malignancies expressed MAGE-1 but not peripheral blood cells from patients with melanoma. 5-Aza-2'-deoxycytidine (DAC), a demethylating agent, was capable of inducing MAGE-1 expression by a MAGE-1-negative melanoma cell line 888-mel as well as by a number of other melanoma cell lines. At an optimum concentration of 1 microM DAC, MAGE-1 expression was detectable by 24 h, plateaued by 72 h, but remained high for two weeks after removal of DAC from treated 888-mel cells, consistent with induction by demethylation. With the exception of tumor-infiltrating leukocytes, no normal diploid cell line could be induced with DAC to upregulate MAGE-1 expression. DAC-treated 888-mel cells were lysed by a MAGE-1-specific major histocompatibility complex restricted cytolytic T-cell clone, whereas control untreated cells were not, suggesting that production of the antigen encoded by the MAGE-1 gene was induced by DAC and that it was presented in association with major histocompatibility complex class I molecules at the cell surface for T-cell recognition.

摘要

MAGE-1是一种编码黑色素瘤细胞系上一种抗原的基因,该抗原可被细胞毒性T细胞识别。我们使用逆转录-聚合酶链反应分析方法,来分析不同类型肿瘤的细胞系、疾病进展不同阶段的黑色素瘤、正常二倍体细胞系以及恶性黑色素瘤所源自的黑素细胞和痣组织中MAGE-1基因的表达情况。MAGE-1在疾病各阶段的黑色素瘤组织中均有表达,但在所检测的黑素细胞、痣组织或任何正常二倍体细胞系中均不表达。源自各种上皮和神经外胚层恶性肿瘤的一部分肿瘤细胞系表达MAGE-1,但黑色素瘤患者的外周血细胞不表达。5-氮杂-2'-脱氧胞苷(DAC),一种去甲基化剂,能够诱导MAGE-1阴性的黑色素瘤细胞系888-mel以及其他一些黑色素瘤细胞系表达MAGE-1。在1 microM DAC的最佳浓度下,24小时即可检测到MAGE-1的表达,72小时达到平台期,但从处理后的888-mel细胞中去除DAC后,其表达在两周内仍保持高水平,这与去甲基化诱导一致。除肿瘤浸润白细胞外,没有正常二倍体细胞系能被DAC诱导上调MAGE-1表达。经DAC处理的888-mel细胞可被MAGE-1特异性的主要组织相容性复合体限制性细胞毒性T细胞克隆裂解,而未处理的对照细胞则不能,这表明MAGE-1基因编码的抗原的产生是由DAC诱导的,并且它与主要组织相容性复合体I类分子在细胞表面结合呈递以供T细胞识别。

相似文献

1
Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.去甲基化剂5-氮杂-2'-脱氧胞苷可上调MAGE-1肿瘤抗原的表达。
Cancer Res. 1994 Apr 1;54(7):1766-71.
2
Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma.BAGE、GAGE和MAGE基因在人胃癌中的表达。
Clin Cancer Res. 1996 Sep;2(9):1619-25.
3
HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.HER-2、gp100和MAGE-1在人类胶质母细胞瘤中表达,并被细胞毒性T细胞识别。
Cancer Res. 2004 Jul 15;64(14):4980-6. doi: 10.1158/0008-5472.CAN-03-3504.
4
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.人类皮肤黑色素瘤中癌/睾丸抗原表达的肿瘤内异质性受甲基化调控,并可被5-氮杂-2'-脱氧胞苷功能逆转。
Cancer Res. 2004 Dec 15;64(24):9167-71. doi: 10.1158/0008-5472.CAN-04-1442.
5
Expression spectrum and methylation-dependent regulation of melanoma antigen-encoding gene family members in pancreatic cancer cells.黑色素瘤抗原编码基因家族成员在胰腺癌细胞中的表达谱及甲基化依赖性调控
Pancreatology. 2002;2(2):146-54. doi: 10.1159/000055905.
6
The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells.DNA 去甲基化剂 5-氮杂-2'-脱氧胞苷诱导髓系白血病细胞中 NY-ESO-1 和其他癌/睾丸抗原的表达。
Leuk Res. 2010 Jul;34(7):899-905. doi: 10.1016/j.leukres.2010.02.004. Epub 2010 Apr 10.
7
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.肿瘤细胞中人类基因MAGE-1的激活与全基因组去甲基化相关。
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7149-53. doi: 10.1073/pnas.93.14.7149.
8
MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte.特定细胞毒性T淋巴细胞裂解黑色素瘤细胞系的MAGE-1表达阈值。
Melanoma Res. 1997 Aug;7 Suppl 2:S83-8.
9
Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.通过CD8(+) T细胞释放粒细胞巨噬细胞集落刺激因子而非细胞溶解作用来检测自然加工且由HLA - A1呈递的黑色素瘤T细胞表位。
Clin Cancer Res. 1996 Jan;2(1):87-95.
10
Expression of MAGE genes in human colorectal carcinoma.黑色素瘤相关抗原(MAGE)基因在人大肠癌中的表达
Ann Surg. 1996 Aug;224(2):183-8. doi: 10.1097/00000658-199608000-00011.

引用本文的文献

1
DNA-demethylation by DAC induces expression and MAGE-specific T cell reactivity against tumors but also healthy cell subsets.DAC介导的DNA去甲基化可诱导基因表达以及针对肿瘤细胞和健康细胞亚群的黑色素瘤相关抗原特异性T细胞反应。
Mol Ther Oncol. 2025 Jul 17;33(3):201018. doi: 10.1016/j.omton.2025.201018. eCollection 2025 Sep 18.
2
Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma.揭示癌症睾丸抗原的重要性及其在神经胶质瘤免疫治疗中的意义。
Discov Oncol. 2024 Oct 29;15(1):602. doi: 10.1007/s12672-024-01449-4.
3
Endogenous Retroviruses Unveiled: A Comprehensive Review of Inflammatory Signaling/Senescence-Related Pathways and Therapeutic Strategies.
内源性逆转录病毒揭秘:炎症信号/衰老相关通路及治疗策略的全面综述
Aging Dis. 2024 May 14;16(2):738-756. doi: 10.14336/AD.2024.0123-1.
4
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer.血清NY-ESO-1和p53抗体作为胃癌有用的肿瘤标志物。
Ann Gastroenterol Surg. 2023 Nov 20;8(2):243-250. doi: 10.1002/ags3.12757. eCollection 2024 Mar.
5
Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043.度伐鲁单抗联合吉西他滨治疗晚期透明细胞肾细胞癌:来自 BTCRC-GU16-043 期 Ib/II 研究的结果。
Nat Commun. 2024 Feb 1;15(1):972. doi: 10.1038/s41467-024-45216-z.
6
Epigenome-Driven Strategies for Personalized Cancer Immunotherapy.基于表观基因组的个性化癌症免疫治疗策略
Cancer Manag Res. 2023 Dec 1;15:1351-1367. doi: 10.2147/CMAR.S272031. eCollection 2023.
7
The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors.嵌合抗原受体巨噬细胞(CAR巨噬细胞),一种针对实体瘤的新一代基于嵌合抗原的方法。
Biomark Res. 2023 Nov 28;11(1):103. doi: 10.1186/s40364-023-00537-x.
8
Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy.表观遗传靶向以增强急性髓系白血病导向的免疫疗法。
Front Immunol. 2023 Sep 22;14:1269012. doi: 10.3389/fimmu.2023.1269012. eCollection 2023.
9
An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.表观遗传学药物治疗癌症和脑部疾病的最新进展:全面综述。
Genes (Basel). 2023 Apr 6;14(4):873. doi: 10.3390/genes14040873.
10
Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS.克服复发:AML 或 MDS 患者异基因移植后使用阿扎胞苷或 FLT3 抑制剂进行预防或先发治疗。
Int J Hematol. 2023 Aug;118(2):169-182. doi: 10.1007/s12185-023-03596-w. Epub 2023 Apr 10.